• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1.25 Contact Hour(s)

    Release Date

    Wednesday, June 20, 2018

    Offline Date

    Monday, December 21, 2020

    ACPE Expiration Date

    Monday, December 21, 2020

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $4.00

    • Overview

      Over the last number of years and even most recently observational studies have surfaced examining the long term safety of proton pump inhibitors, most notably the prescription PPIs. Some of the long term effects that have been observed in these studies include dementia, fractures, kidney disease, nutrient malabsorption, infections and most recently death. Despite all of the data that has been published it is important to look more closely at these studies since they are only observational and not randomized controlled trials. Unfortunately this information is readily available to the public via the media and it continues to pose concerns for not only patients but clinicians as well. It is important for pharmacists to be educated on this topic so they can appropriately communicate with their patients and prescribers on this class of medication.

      Handouts

      • Slide Document :   17222H01_4pp.pdf
      • Slide Document :   17222H01_2pp.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      Identify the long term safety concerns of the class of PPIs including the mechanism of action
      Keeping in mind the features of observational studies, analyze the study data pertaining to PPIs
      Based on the conclusions of observational studies, communicate findings with patients and other clinicians
      Review the indication and safety profile of the currently FDA approved prescription proton pump inhibitors

      Pharmacy Technician

      Recognize warnings associated with the use of PPIs that are listed in the product package inserts
      Review the indications for the current FDA approved prescription and nonprescription proton pump inhibitors (PPIs)
      Distinguish between randomized controlled studies trials and observational studies

      Nurse

      Identify the long term safety concerns of the class of PPIs including the mechanism of action
      Keeping in mind the features of observational studies, analyze the study data pertaining to PPIs
      Review the indication and safety profile of the currently FDA approved prescription proton pump inhibitors
      Based on the conclusions of observational studies, communicate findings with patients and other clinicians
    • Activity Type

      Knowledge

      CE Broker

      20-627765

      Universal Activity Number

      Pharmacist 0798-0000-17-222-H01-P
      Pharmacy Technician 0798-0000-17-222-H01-T
      Nurse 0798-0000-17-222-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    • Faculty

      Brooke  Fidler, PharmD
      Associate Professor, LIU Pharmacy, Arnold & Marie Schwartz College of Pharmacy and Health Sciences

    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).